134 related articles for article (PubMed ID: 8631864)
21. Stimulation of GM3 ganglioside sialidase activity by an activator protein in patients with mucolipidosis IV and controls.
Ben-Yoseph Y; Mitchell DA; Yager RM; Pretzlaff RK
Enzyme; 1991; 45(1-2):23-9. PubMed ID: 1806363
[TBL] [Abstract][Full Text] [Related]
22. A Pro504 --> Ser substitution in the beta-subunit of beta-hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease.
Hou Y; McInnes B; Hinek A; Karpati G; Mahuran D
J Biol Chem; 1998 Aug; 273(33):21386-92. PubMed ID: 9694901
[TBL] [Abstract][Full Text] [Related]
23. A GM2-specific beta-hexosaminidase from the roe of striped mullet (Mugil cephalus).
DeGasperi R; Li SC; Li YT
J Biol Chem; 1988 Jan; 263(3):1325-8. PubMed ID: 2961751
[TBL] [Abstract][Full Text] [Related]
24. Molecular analysis of a GM2-activator deficiency in two patients with GM2-gangliosidosis AB variant.
Schepers U; Glombitza G; Lemm T; Hoffmann A; Chabas A; Ozand P; Sandhoff K
Am J Hum Genet; 1996 Nov; 59(5):1048-56. PubMed ID: 8900233
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis.
Vyas M; Deschenes NM; Osmon KJL; Chen Z; Ahmad I; Kot S; Thompson P; Richmond C; Gray SJ; Walia JS
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834060
[TBL] [Abstract][Full Text] [Related]
26. GM2 ganglioside activator occurs in multiple forms.
Novak A; Lowden JA
Biochim Biophys Acta; 1994 Mar; 1199(2):209-14. PubMed ID: 8123670
[TBL] [Abstract][Full Text] [Related]
27. Interaction of GM2 activator protein with glycosphingolipids.
Li SC; Hama Y; Li YT
Adv Exp Med Biol; 2001; 491():351-67. PubMed ID: 14533808
[TBL] [Abstract][Full Text] [Related]
28. Identification of domains in human beta-hexosaminidase that determine substrate specificity.
Pennybacker M; Liessem B; Moczall H; Tifft CJ; Sandhoff K; Proia RL
J Biol Chem; 1996 Jul; 271(29):17377-82. PubMed ID: 8663217
[TBL] [Abstract][Full Text] [Related]
29. Substrate binding properties of the human liver hexosaminidase A activator protein.
Hechtman P; Isaacs C; Smith-Jones L
Can J Biochem Cell Biol; 1985 Aug; 63(8):830-8. PubMed ID: 2933135
[TBL] [Abstract][Full Text] [Related]
30. A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside.
Sharma R; Bukovac S; Callahan J; Mahuran D
Biochim Biophys Acta; 2003 Jan; 1637(1):113-8. PubMed ID: 12527415
[TBL] [Abstract][Full Text] [Related]
31. Over-expression of a functionally active human GM2-activator protein in Escherichia coli.
Klima H; Klein A; van Echten G; Schwarzmann G; Suzuki K; Sandhoff K
Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):571-6. PubMed ID: 8503891
[TBL] [Abstract][Full Text] [Related]
32. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice.
Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K
Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605
[TBL] [Abstract][Full Text] [Related]
33. Refined mapping of the GM2 activator protein (GM2A) locus to 5q31.3-q33.1, distal to the spinal muscular atrophy locus.
Heng HH; Xie B; Shi XM; Tsui LC; Mahuran DJ
Genomics; 1993 Nov; 18(2):429-31. PubMed ID: 8288250
[TBL] [Abstract][Full Text] [Related]
34. Two mechanisms for the recapture of extracellular GM2 activator protein: evidence for a major secretory form of the protein.
Rigat B; Wang W; Leung A; Mahuran DJ
Biochemistry; 1997 Jul; 36(27):8325-31. PubMed ID: 9204879
[TBL] [Abstract][Full Text] [Related]
35. The GM2 activator protein, its roles as a co-factor in GM2 hydrolysis and as a general glycolipid transport protein.
Mahuran DJ
Biochim Biophys Acta; 1998 Jul; 1393(1):1-18. PubMed ID: 9714704
[TBL] [Abstract][Full Text] [Related]
36. Degradation of membrane-bound ganglioside GM2 by beta -hexosaminidase A. Stimulation by GM2 activator protein and lysosomal lipids.
Werth N; Schuette CG; Wilkening G; Lemm T; Sandhoff K
J Biol Chem; 2001 Apr; 276(16):12685-90. PubMed ID: 11278374
[TBL] [Abstract][Full Text] [Related]
37. Structural organization and expression of the gene for the mouse GM2 activator protein.
Bertoni C; Appolloni MG; Stirling JL; Li SC; Li YT; Orlacchio A; Beccari T
Mamm Genome; 1997 Feb; 8(2):90-3. PubMed ID: 27518306
[TBL] [Abstract][Full Text] [Related]
38. GM2 gangliosidosis AB variant: first case of late onset and review of the literature.
Ganne B; Dauriat B; Richard L; Lamari F; Ghorab K; Magy L; Benkirane M; Perani A; Marquet V; Calvas P; Yardin C; Bourthoumieu S
Neurol Sci; 2022 Nov; 43(11):6517-6527. PubMed ID: 35925454
[TBL] [Abstract][Full Text] [Related]
39. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis.
Martin DR; Cox NR; Morrison NE; Kennamer DM; Peck SL; Dodson AN; Gentry AS; Griffin B; Rolsma MD; Baker HJ
Acta Neuropathol; 2005 Nov; 110(5):443-50. PubMed ID: 16200419
[TBL] [Abstract][Full Text] [Related]
40. Cloning and sequence analysis of a cDNA clone coding for the mouse GM2 activator protein.
Bellachioma G; Stirling JL; Orlacchio A; Beccari T
Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):227-30. PubMed ID: 7689829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
